The post-test for this issue is available for one year after the publication date to subscribers. By successfully completing the test you will be awarded a certificate for 2 CME credits.
Read More
People can still find meaningful lives even in with the most debilitating medical disorders, including locked in syndrome. In this neurologic disorder, patients maintain full awareness but are unable to speak or move due to complete paralysis of nearly all voluntary muscles in the body.
Read More
The Walmart of Mental Health. Walmart launched its first line of behavioral health clinics in rural Georgia this year with plans to expand rapidly. The discount chain will focus on rural communities where access to care is low and lack of insurance is high, with low-cost, self-pay services. Currently it...
Read More
Dysphoric states cause intense anxiety and an urgent need to get relief. They can drive patients to self-harm, substance abuse, and suicide. Greg Sazima describes a breathing technique that helps patients pass safely through these crises.
Read More
You don’t need to be a psychoanalyst or DBT specialist to help patients with borderline personality disorder. Lois Choi-Kain developed a psychotherapeutic approach that can be woven into just about any psychiatric treatment, from the medication visit to the hospital wards.
Read More
Provigil and Nuvigil, the modafinils, may not work for full depressive episodes, but they do something else in bipolar disorder that’s important to patients. This article explores their cognitive effects, as well as their potential to cause addiction and mania.
Read More
Joe Goldberg believes we do a disservice by shuffling patients through medication trials that have little chance of working. He shares techniques to engage patients, motivate change, combat demoralization, as well as his top pharmacologic strategies for highly resistant depression.
Read More
The mysterious rise in autism diagnoses has invited every type of conjecture, from vaccines to aging parents. By comparing it to the rate of schizophrenia, this study arrived at an answer that’s a little more mundane, but a lot less speculative.
Read More
Dr. Aiken is the Editor in Chief of The Carlat Psychiatry Report; director of the Mood Treatment Center in North Carolina, where he maintains a private practice combining medication and therapy along with evidence-based complementary and alternative treatments; and Assistant Professor NYU Langone Department of Psychiatry. He has worked as a research assistant at the NIMH and a sub-investigator on clinical trials, and conducts research on a shoestring budget out of his private practice. Follow him on Twitter and find him on LinkedIn.
_-The-Breakthrough-Antipsychotic-That-Could-Change-Everything.jpg?1729528747 "KarXT (Cobenfy)_ The Breakthrough Antipsychotic That Could Change Everything.jpg")
